Ceribell Expands Its Point-of-Care Brain Monitoring Platform with Commercial Launch of Delirium Monitoring Solution
Commercial launch follows successful pilot, with customers reporting improved clinical decision-making and greater confidence in care decisions Commercial launch follows successful pilot, with customers reporting improved clinical decision-making and greater confidence in care decisions
Covered in this story
Call it yourself
No calls on $CBLL yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Ceribell Inc →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.